Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
46.4
％（第2四半期累計・親会社株主に帰属する四半期純利益）Wording
Avoiding a definitive answer
How definitive the wording is.Revised forecast
Fiscal year ending March 2025 · Cumulative second quarter, full yearPrevious forecast published 10 May 2024Net Sales2Q cumulative31,600→34,000million
+7.6%
Net SalesFull year65,000→68,000million
+4.6%
Operating profit2Q cumulative5,050→7,200million
+42.6%
Operating profitFull year11,150→13,500million
+21.1%
Ordinary income2Q cumulative5,100→7,350million
+44.1%
Ordinary incomeFull year11,250→13,700million
+21.8%
Profit attributable to owners of the parent2Q cumulative3,450→5,050million
+46.4%
Profit attributable to owners of the parentFull year7,400→9,150million
+23.6%
Net income per share2Q cumulative97.87→143.26yen and sen
+46.4%
Net income per shareFull year209.93→259.57yen and sen
+23.6%
The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Reason for the revision
ライフサイエンス事業は国内外とも堅調に推移し、計画をわずかながら上回る見込み。電子材料および機能性化学品事業は半導体市場が緩やかに回復し、超高純度コロイダルシリカの売上高が計画を上回る見込みで、売上増加と増産によるコストダウン効果により利益も計画を上回る見込み。市況・生産能力・在庫状況・為替等を改めて精査した結果、計画値を上回る見込みとなったため修正。
Details and amount of extraordinary loss
固定資産除却損12,232千円（当第1四半期連結累計期間）
Previous-period results2Q cumulative 売上高27,135百万円、営業利益5,581百万円、経常利益6,245百万円、親会社株主に帰属する四半期純利益4,287百万円、1株当たり四半期純利益121.64円 / Full year 売上高58,970百万円、営業利益11,083百万円、経常利益11,883百万円、親会社株主に帰属する当期純利益8,343百万円、1株当たり当期純利益236.70円
Dividend forecast revisionNo change (whether the dividend forecast has been revised from the most recently announced forecast: No)
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | 2Q cumulative 31,600 / Full year 65,000 → 2Q cumulative 34,000 / Full year 68,000（2Q cumulative 7.6 / Full year 4.6） |
| Operating profit | 2Q cumulative 5,050 / Full year 11,150 → 2Q cumulative 7,200 / Full year 13,500（2Q cumulative 42.6 / Full year 21.1） |
| Ordinary income | 2Q cumulative 5,100 / Full year 11,250 → 2Q cumulative 7,350 / Full year 13,700（2Q cumulative 44.1 / Full year 21.8） |
| Profit attributable to owners of the parent | 2Q cumulative 3,450 / Full year 7,400 → 2Q cumulative 5,050 / Full year 9,150（2Q cumulative 46.4 / Full year 23.6） |
| Net income per share | 2Q cumulative 97.87 / Full year 209.93 → 2Q cumulative 143.26 / Full year 259.57 |
| Fiscal Period Covered | Fiscal year ending March 2025 |
| Period Covered | Cumulative second quarter, full year |
| Publication date of previous forecast | 10 May 2024 |
| Previous-period results | 2Q cumulative 売上高27,135百万円、営業利益5,581百万円、経常利益6,245百万円、親会社株主に帰属する四半期純利益4,287百万円、1株当たり四半期純利益121.64円 / Full year 売上高58,970百万円、営業利益11,083百万円、経常利益11,883百万円、親会社株主に帰属する当期純利益8,343百万円、1株当たり当期純利益236.70円 |
| Reason for the revision | ライフサイエンス事業は国内外とも堅調に推移し、計画をわずかながら上回る見込み。電子材料および機能性化学品事業は半導体市場が緩やかに回復し、超高純度コロイダルシリカの売上高が計画を上回る見込みで、売上増加と増産によるコストダウン効果により利益も計画を上回る見込み。市況・生産能力・在庫状況・為替等を改めて精査した結果、計画値を上回る見込みとなったため修正。 |
| Details and amount of extraordinary loss | 固定資産除却損12,232千円（当第1四半期連結累計期間） |
| Dividend forecast revision | No change (whether the dividend forecast has been revised from the most recently announced forecast: No) |
| Consolidated / non-consolidated | Consolidated |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.ライフサイエンス事業が国内外で堅調に推移し、電子材料および機能性化学品事業では半導体市場の緩やかな回復や超高純度コロイダルシリカの販売増加が見込まれるためです。加えて、増産によるコストダウン効果も利益の上振れ要因としています。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.